Circulating Neprilysin Level Predicts the Risk of Cardiovascular Events in Hemodialysis Patients

Background: Neprilysin inhibition has demonstrated impressive benefits in heart failure treatment, and is the current focus of interest in cardiovascular (CV) and kidney diseases. However, the role of circulating neprilysin as a biomarker for CV events is unclear in hemodialysis (HD) patients. Metho...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Cardiovasc Med
Auteurs principaux: Hwang, Hyeon Seok, Kim, Jin Sug, Kim, Yang Gyun, Lee, Yu Ho, Lee, Dong-Young, Ahn, Shin Young, Moon, Ju-Young, Lee, Sang-Ho, Ko, Gang-Jee, Jeong, Kyung Hwan
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2021
Sujets:
Cardiovascular Medicine
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8239158/
https://ncbi.nlm.nih.gov/pubmed/34212014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2021.684297
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires